Therapeutics acquisition corp stock. Therapeutics Acquisition stock quote and RACA charts.
Therapeutics acquisition corp stock. , formerly Therapeutics Acquisition Corp, is a late-stage clinical precision oncology company. It intends to identify and acquire a business focusing on the healthcare industry. NASDAQ RACA Add to watchlist $10. Jul 10, 2020 · The Company’s shares of Class A common stock began trading on The Nasdaq Capital Market under the ticker symbol “TXAC” on July 8, 2020. (TXAC) flew out of the gates today, rising 22% on its first day on the market. Perplexity is a free AI-powered answer engine that provides accurate, trusted, and real-time answers to any question. Check the Therapeutics Acquisition stock price today on the NASDAQ stock exchange and access historical RACA stock price chart. Jun 25, 2025 · With the completion of the acquisition, shares of common stock, par value $0. 001 per share (the “Shares”), of Regulus, have ceased trading on the Nasdaq Stock Market LLC and Regulus is now an indirect wholly owned subsidiary of Novartis. Jul 8, 2020 · The special purpose acquisition company is sponsored by RA Capital Management. bhoba a8 wj4qkh p1wja 3mcpp 2td rnb xim tj n6tobws